|
|
Article: Marine biotech business gets funding boost.
- Article from:
- Pharma Business Week
- Article date:
- March 17, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 MAR 17 - (NewsRx.com & NewsRx.net) -- An Edinburgh-based marine biotech business has been given a UKP50,000 boost in its bid to scour tidal areas such as rock pools to find and develop new drugs and antibiotics, including a new compound found to be active against the hospital "superbug" methicillin-resistant Staphylococcus aureus (MRSA).
AquaPharm Bio-Discovery Ltd. received this award from the National Endowment for Science, Technology, and the Arts (NESTA), the organization that invests in U.K. creativity and innovation.
AquaPharm was founded in 2000 and is headed by Dr. Andrew Mearns Spragg, an entrepreneurial scientist with over seven years of ...